IONS vs LQDA: stock comparison and AI forecast
Ionis Pharmaceuticals Inc (IONS) and Liquidia Corp (LQDA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
IONS Ionis Pharmaceuticals Inc
- Price
- $28.19 -62.8% · 6M
- Market Cap
- $4.68B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
LQDA Liquidia Corp
- Price
- $47.87 -9.9% · 6M
- Market Cap
- $4.60B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- IONS and LQDA have similar market capitalizations ($4.68B and $4.60B).
- Over the last six months LQDA returned -9.9% and IONS -62.8%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | IONS | LQDA |
|---|---|---|
| Market Cap | $4.68B | $4.60B |
| P/B Ratio | 11.90x | – |
| EPS | $-2.93 | $-2.66 |
| Book Value/Share | $2.37 | – |
| Revenue/Share | $2.11 | $7.08 |
| FCF/Share | $-3.71 | $3.25 |
Profitability & Margins
| Metric | IONS | LQDA |
|---|---|---|
| ROE | -138.8% | – |
| ROA | -18.8% | – |
| ROIC | -22.8% | -99.2% |
| Gross Margin | 95.2% | – |
| Operating Margin | -160.8% | -15.3% |
| Net Margin | -155.6% | – |
| EBT Margin | -154.8% | -17.1% |
| Tax Rate | -0.5% | 17.7% |
Financial Health
| Metric | IONS | LQDA |
|---|---|---|
| Current Ratio | 5.43x | 1.02x |
| Quick Ratio | 5.36x | 0.96x |
| D/E Ratio | 6.40x | – |
| Financial Leverage | 7.40x | – |
| Interest Coverage | -28.2x | -9.7x |
| Working Capital | $1.93B | $11M |
Cash Flow
| Metric | IONS | LQDA |
|---|---|---|
| Operating Cash Flow | -$544M | $324M |
| Free Cash Flow | -$616M | $291M |
| Capital Spending | -$72M | -$33M |
| FCF/Sales | -175.4% | 45.9% |
| CapEx/Sales | 20.4% | 5.2% |
Operational Efficiency
| Metric | IONS | LQDA |
|---|---|---|
| Asset Turnover | 0.12x | 0.93x |
| Receivables Turnover | – | 5.9x |
| Inventory Turnover | 0.6x | – |
| Fixed Assets Turnover | 2.2x | 14.2x |
| Days Sales Outstanding | – | 61 days |
| Days Inventory | 614 days | – |
| Payables Period | 582 days | – |
Income Statement
| Metric | IONS | LQDA |
|---|---|---|
| Total Revenue | $351M | $634M |
| Operating Income | -$565M | -$97M |
| Net Income | -$547M | – |
| R&D Expense | – | $72M |
| SG&A Expense | $585M | $242M |
| Cost of Goods Sold | $17M | – |
Dividend & Shareholder Information
| Metric | IONS | LQDA |
|---|---|---|
| Shares Outstanding | 166M | 90M |
IONS vs LQDA: stock comparison and AI forecast
Which is bigger, IONS or LQDA?
IONS and LQDA have similar market capitalizations ($4.68B and $4.60B).
Which stock performed better over the last six months, IONS or LQDA?
Over the last six months LQDA returned -9.9% and IONS -62.8%.
Which one does Intratio's AI model rank higher, IONS or LQDA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.